Article

Official Statement on UFC Brisbane

Zuffa, LLC, owner of the Ultimate Fighting Championship®, released the following statement today regarding drug test results from UFC FIGHT NIGHT that took place in Brisbane, Australia, on Dec. 7, 2013.

All fighters on the UFC FIGHT NIGHT card were drug tested by an independent third-party laboratory at the event and all fighters passed their drug tests with the exception of Antonio “Bigfoot” Silva. Although Silva is on a medically approved regimen of Testosterone Replacement Therapy (TRT), and had been in compliance with therapeutic guidelines on all pre-fight tests performed prior to the event, the results of his test on the day of the event indicated a level of testosterone outside of allowable limit. Silva has been informed that the elevated testosterone level is a violation of the UFC Fighter Conduct Policy and his Promotional Agreement with Zuffa.  He will receive a nine month suspension retroactive to the date of the event and he must pass a drug test upon completion of the suspension before receiving clearance to compete again. Additionally, he will forfeit $50,000 in bonus money. The forfeited bonus will go to his opponent Mark Hunt.
Sunday, May 27
1PM/10AM
ETPT
Liverpool, United Kingdom

Media

Recent
After defeating Demian Maia by unanimous decision at UFC Fight Night Chile, Kamaru Usman believes that he is the most dangerous welterweight in the world.
May 19, 2018
Kamaru Usman extended his welterweight win-streak to eight, after defeating Demian Maia by unanimous decision in the main event of UFC Fight Night Chile. Watch Usman's Octagon interview where he discusses the performance and what's next at welterweight.
May 19, 2018
Tatiana Suarez remained undefeated after finishing Alexa Grasso with a rear naked choke in the first round of her bout on UFC Fight Night Chile on FS1. Watch Suarez's Octagon interview where she discusses the performance and requests a top 10 showdown.
May 19, 2018
Watch the post-fight press conference live following the event.
May 19, 2018